Zarei Mahdi, Hajipoor Kashgsaray Nasim, Asheghi Milad, Shahabifard Hesam, Soleimanpour Hassan
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Emergency and Trauma Care Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Anesth Pain Med. 2022 Nov 22;12(5):e132904. doi: 10.5812/aapm-132904. eCollection 2022 Oct.
Migraine is one of the most common causes of disability worldwide and the sixth cause of loss of life years due to disability. Migraine is reported mainly in young and middle-aged people, so it can cause a person to face many problems in doing daily tasks. The emergency department annually accepts 1.2 million patients with migraine. Therefore, timely diagnosis of the disease, knowledge of valuable drugs in an emergency, knowing how to use them, and finally, early treatment can play an essential and decisive role in improving patients' symptoms and reducing the disability caused by the disease. An essential and valuable drug category in the emergency department to manage pain is non-opioid intravenous (IV) drugs. Therefore, this study aimed to evaluate non-opioid IV drugs to manage pain in patients with acute migraines in the emergency department.
This study conducted a comprehensive literature review to access the latest scientific studies and documents using keywords (acute migraine, non-opioid IV drugs, pain management) in reliable databases such as PubMed, Scopus, Web of Science, Cochrane, and Google Scholar. We reviewed 87 articles, 53 of which were evaluated and compared.
A review study considers intravenous acetaminophen as a suitable option for the first-line treatment of acute migraine in the emergency department if the patient does not tolerate aspirin and non-steroidal anti-inflammatory drugs (NSAIDs). Various studies have obtained positive effects of NSAIDs and dihydroergotamine (DHE) in treating acute migraine. Prescribing anti-dopaminergic drugs can effectively reduce associated symptoms such as nausea and vomiting. Dexamethasone and magnesium sulfate are effective in preventing migraine and severe attacks. Intravenous sodium valproate is effective in moderate to severe migraine attacks or treatment-resistant migraines. In the emergency department, prescribing intravenous haloperidol, lidocaine, and propofol can help manage migraine and improve other associated symptoms, such as nausea or vomiting.
Non-opioid IV drugs are essential to manage pain and improve other migraine symptoms in the emergency setting. Knowing the above drugs and their optimal use has a decisive role in managing patients with acute migraine in the emergency department.
偏头痛是全球致残的最常见原因之一,也是因残疾导致生命年损失的第六大原因。偏头痛主要在年轻人和中年人中报道,因此它会导致一个人在进行日常任务时面临许多问题。急诊科每年接诊120万名偏头痛患者。因此,及时诊断疾病、了解急诊中有价值的药物、知道如何使用这些药物,最后进行早期治疗,对于改善患者症状和减少疾病导致的残疾至关重要且具有决定性作用。急诊科用于管理疼痛的一类重要且有价值的药物是非阿片类静脉注射药物。因此,本研究旨在评估非阿片类静脉注射药物在急诊科管理急性偏头痛患者疼痛方面的效果。
本研究进行了全面的文献综述,以使用关键词(急性偏头痛、非阿片类静脉注射药物、疼痛管理)在诸如PubMed、Scopus、科学网、Cochrane和谷歌学术等可靠数据库中获取最新的科学研究和文献。我们审查了87篇文章,其中53篇进行了评估和比较。
一项综述研究认为,如果患者不耐受阿司匹林和非甾体抗炎药(NSAIDs),静脉注射对乙酰氨基酚是急诊科急性偏头痛一线治疗的合适选择。各种研究已获得NSAIDs和双氢麦角胺(DHE)治疗急性偏头痛的积极效果。开具抗多巴胺能药物可有效减轻恶心和呕吐等相关症状。地塞米松和硫酸镁在预防偏头痛和严重发作方面有效。静脉注射丙戊酸钠对中度至重度偏头痛发作或难治性偏头痛有效。在急诊科,开具静脉注射氟哌啶醇、利多卡因和丙泊酚有助于管理偏头痛并改善其他相关症状,如恶心或呕吐。
非阿片类静脉注射药物对于在急诊环境中管理疼痛和改善其他偏头痛症状至关重要。了解上述药物及其最佳使用方法在急诊科管理急性偏头痛患者方面具有决定性作用